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Abstract
Digital peripheral arterial tonometry (PAT) is an emerging, non-invasive method to assess
vascular function. The physiology underlying this phenotype, however, remains unclear.
Therefore, we evaluated the relationship between digital PAT and established brachial artery
ultrasound measures of vascular function under basal conditions and following reactive
hyperemia. Using a cross-sectional study design, digital PAT and brachial artery ultrasound with
pulsed wave Doppler were simultaneously completed at baseline and following reactive
hyperemia in both individuals with established coronary artery disease (n=99) and healthy
volunteers at low cardiovascular disease risk (n=40). Under basal conditions, the digital pulse
volume amplitude demonstrated a significant positive correlation with the brachial artery velocity-
time integral, that was independent of arterial diameter, in both the healthy volunteer (rs=0.64,
P<0.001) and coronary artery disease (rs=0.63, P<0.001) cohorts. Similar positive relationships
were observed with baseline brachial artery blood flow velocity and blood flow. In contrast, no
relationship between the reactive hyperemia-evoked digital PAT ratio and either brachial artery
flow-mediated dilation or shear stress was observed in either cohort (P=NS). In conclusion, these
findings demonstrate that digital PAT measures of vascular function more closely reflect basal
blood flow in the brachial artery than reactive hyperemia-induced changes in arterial diameter or
flow velocity, and the presence of vascular disease does not modify the physiology underlying the
digital PAT phenotype.
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Endothelial dysfunction is integral to the pathogenesis and progression of coronary artery
disease (CAD).1 Brachial artery flow-mediated dilation (FMD) is the most widely used non-
invasive method to assess endothelial function; however, technical complexity and lack of
standardization limit its clinical application.2 Digital peripheral arterial tonometry (PAT)
quantifies reactive hyperemia-induced changes in pulse volume amplitude (PVA) in the
finger tip, and is an emerging, automated method to non-invasively assess endothelial
function.3 Digital PAT is predictive of the presence of cardiovascular disease risk factors,4–7
impaired vasodilator responses to acetylcholine in coronary arteries,8,9 and adverse
cardiovascular events in a single study.10 Although prior studies have demonstrated a direct
contribution of nitric oxide to brachial artery FMD11 and the digital PAT ratio,12 conflicting
results regarding their correlation have been reported.5,6,13–15 Despite growing interest in
the utility of digital PAT, the physiology underlying the digital PVA signal and its
relationship with established vascular function phenotypes remains unclear. In particular, the
relationship between digital PVA and brachial artery blood flow velocity, and the impact of
vascular disease on these phenotypes, has not been rigorously evaluated. Therefore, we
characterized the relationship between digital PAT and brachial artery ultrasound vascular
function phenotypes, under both basal and reactive hyperemia-evoked conditions, in healthy
volunteers and individuals with established CAD.
METHODS
Individuals with established CAD (defined as ≥50% stenosis in at least one major epicardial
coronary artery by coronary angiography) were identified in the University of North
Carolina Cardiac Catheterization Laboratory. Exclusion criteria included pregnancy, atrial
fibrillation, Raynaud’s disease, left-ventricular ejection fraction ≤35%, current use of insulin
or long-acting nitrates, active autoimmune disease, history of severe aortic stenosis, history
of solid organ transplant or dialysis, or history of cancer within the previous 5 years.
A parallel cohort of healthy volunteers (HV) was identified by advertisement from the local
Chapel Hill, NC community. Following a detailed history and a fasting serum chemistry and
cholesterol panel, potential participants were excluded if they had a history of cardiovascular
disease, risk factors for CAD [including physician-diagnosed hypertension or diabetes,
cigarette smoking within the previous 6 months, high cholesterol (defined as total
cholesterol >240 mg/dL, triglycerides >200 mg/dL or low density lipoprotein cholesterol
>160 mg/dL), or a body mass index >30 kg/m2], or were currently taking any medication for
a chronic medical condition.
The study protocol was approved by the University of North Carolina at Chapel Hill
Biomedical Institutional Review Board. Eligible participants (108 CAD, 41 HV) provided
written informed consent and returned to the clinical research unit for a single morning
study visit after fasting overnight and withholding their morning medications. Participants
were instructed to refrain from tobacco products, caffeine, and vigorous exercise the
morning of the study visit, and from use of vitamin C, vitamin E, fish oil, niacin or arginine
supplements, oral decongestants, non-steroidal anti-inflammatory drugs (other than low-
dose aspirin), or erectile dysfunction medications for at least 7 days prior to the study visit.
Individuals who experienced a respiratory tract infection within 4 weeks prior to the study
visit were not eligible to participate.
Endothelial function measurements were completed in a quiet, dimly lit, temperature-
controlled room and obtained while the participant lay in a supine position. Following 10
minutes of rest, brachial artery reactivity was assessed by quantifying arterial diameter and
blood flow velocity at baseline and following reactive hyperemia using a 12.5-MHz linear-
array transducer (Philips HDI 5000 system) with pulsed wave Doppler, as described.16,17
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Reactive hyperemia was induced by inflating a blood pressure cuff around the right forearm
for 5 minutes to a pressure of at least 70 mmHg greater than the systolic blood pressure. All
images were electrocardiogram gated and obtained by the same sonographer throughout the
study. Data were analyzed by the Brachial Tools software (Medical Imaging Applications,
Coralville, IA).
Brachial artery diameter was measured at end diastole from the lumen-intimal interface of
the proximal and distal walls. Baseline diameter was averaged from 10 consecutive frames.
Arterial diameter was assessed for 90 seconds following cuff deflation, and the diameter
during peak dilation was averaged from 3 consecutive frames. The peak change in arterial
dilation was observed 51 ± 12 (mean ± standard deviation) seconds after cuff deflation.
Brachial artery FMD (endothelium-dependent) was calculated as the percent change in
brachial artery diameter from baseline [= 100*(diameter Peak − diameter Baseline)/
(diameter Baseline)]. The reproducibility of this method in our laboratory has been previously
reported.16 Following 10 minutes of rest, a second baseline image was acquired, which was
highly correlated with the initial baseline measurement (r=0.99, P<0.001). Endothelial-
independent vasodilation was assessed 5 minutes following sublingual administration of
nitroglycerin (0.4 mg) as the percent change in arterial diameter [=
100*(diameter Nitroglycerin − diameter Baseline)/(diameter Baseline)].
Brachial artery blood flow velocity was measured by pulsed wave Doppler at baseline and
for 15 seconds following cuff deflation. The velocity-time integral (VTI) was measured by
automated planimetry of the velocity profile and averaged over 3 consecutive cardiac cycles
at baseline and during peak reactive hyperemia. The reactive hyperemia-induced increase in
VTI relative to baseline was calculated as a ratio [= VTI RH/VTI Baseline]. The mean flow
velocity (V) was calculated by dividing the VTI (cm) by the duration of the cycle (s). Mean
flow velocity was converted to local shear stress [= 8*μ*Vx/diameter Baseline] and blood
flow [= Vx*π*(diameter Baseline/2)2], as described,18,19 which each normalize flow velocity
to arterial diameter. The subscript x indicates either baseline or peak reactive hyperemia, and
μ indicates blood viscosity at an assumed value of 0.035 dyne*s/cm2. Since reactive
hyperemia-induced flow velocity changes in conduit arteries are regulated by dilation of
distal resistance vessels, brachial shear stress following reactive hyperemia (SSRH) is as an
index of microvascular function.18,19
Digital PVA was measured on the index finger of each hand using plethysmographically
based probes and the Endo-PAT 2000 device (Itamar Medical Ltd, Caesarea, Israel)
simultaneously with the brachial artery ultrasound measurements. Measurements were
obtained continuously during the baseline (5 minutes), cuff occlusion (5 minutes), and post-
cuff deflation (5 minutes) periods, and the data were automatically derived using the Endo-
PAT v3.0.4 software. The digital PAT ratio was calculated as the ratio of post-cuff deflation
PVA (in 30 second intervals) to baseline PVA in the arm undergoing cuff occlusion
(occluded), and then normalized to the contralateral (control) arm. The digital PAT ratio in
the 90–120 second post-cuff deflation interval [= (PVA occluded, 90–120sec/
PVA occluded, Baseline)/(PVA control, 90–120sec/PVA control, Baseline)] is presented, as
described,4 unless otherwise noted. The digital PAT test was unsuccessful in 10 study
participants (9 CAD, 1 HV), consistent with prior reports.4,6 The reproducibility of this
automated method has been previously established.20
Data presented as mean ± standard deviation or median (interquartile range). Study
population characteristics were compared using a one-way analysis of variance or Wilcoxon
rank-sum test, where appropriate. Relationships between each digital PAT and brachial
artery ultrasound phenotype were evaluated by Spearman rank correlation (rs). Partial
correlations were also evaluated to account for the potential impact of demographic (age,
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sex, race) and vascular (baseline brachial artery diameter, baseline brachial artery VTI,
baseline digital PVA, SSRH) variables on these relationships. Parameters that were not
normally distributed, including digital PVA and PAT ratio, were log10-transformed prior to
graphical presentation. Since the units of each digital PAT and brachial artery ultrasound
measure were not the same, Bland–Altman plots could not be constructed to evaluate the
agreement between each phenotype.21 Analyses were performed using SAS 9.2 (SAS
Institute, Cary, NC). Statistical significance was set at P<0.05.
RESULTS
The cohort characteristics are provided in Table 1. Participants in the CAD cohort returned
for their study visit 61 ± 33 days following cardiac catheterization. High rates of statin,
renin-angiotensin system inhibitor, beta blocker, aspirin and clopidogrel use were reported,
consistent with management of the CAD cohort according to current clinical practice
guidelines.
Under basal conditions, the digital PVA and brachial artery diameter were modestly
correlated in both cohorts (Figure 1A, 1B); however, these correlations were not statistically
significant when adjusting for age, sex and race (HV: rs=0.21, P=0.208; CAD: rs=0.12,
P=0.260). The baseline digital PVA demonstrated a significant positive correlation with
basal brachial artery VTI that was similar in both cohorts (Figure 1C, 1D). After stratifying
by sex, significant relationships were observed in women (HV: rs=0.80, P<0.001; CAD:
rs=0.65, P<0.001) and men (HV: rs=0.55, P=0.023; CAD: rs=0.66, P<0.001). Similar
relationships were also observed after adjusting for age, sex, race and brachial artery
diameter (HV: rs=0.71, P<0.001; CAD: rs=0.72, P<0.001), and when the data were
expressed as mean flow velocity (HV: rs=0.56, P<0.001; CAD: rs=0.62, P<0.001), blood
flow (HV: rs=0.78, P<0.001; CAD: rs=0.72, P<0.001) or shear stress (Figure 1E, 1F), further
demonstrating a positive relationship between basal digital PVA and brachial artery blood
flow velocity that is independent of arterial size.
A significant positive relationship between brachial artery FMD and SSRH (HV: rs=0.64,
P<0.001; CAD: rs=0.54, P<0.001), which serves as the stimulus for arterial dilation, and a
significant inverse relationship between digital PAT ratio and baseline PVA (HV: rs=−0.63,
P<0.001; CAD: rs=−0.79, P<0.001) was observed in both cohorts. A significant inverse
relationship between age and brachial artery FMD (HV: rs=−0.33, P=0.037; CAD: rs=−0.33,
P=0.001), but not digital PAT ratio (HV: rs=0.05, P=0.737; CAD: rs=0.08, P=0.403), was
observed in both cohorts. No significant relationship between digital PAT ratio and FMD
was observed in either cohort (Figure 2A, 2B). Similar results were observed after adjusting
for age, sex, race and SSRH (HV: rs=−0.02, P=0.925; CAD: rs=−0.01, P=0.930), as well as
in each 30-second post-cuff deflation interval utilized for the digital PAT ratio calculation
(data not shown). No relationship between digital PAT ratio and nitroglycerin-mediated
dilation was observed in either cohort (HV: rs=0.13, P=0.454; CAD: rs=0.17, P=0.092).
In contrast, a significant positive relationship between digital PAT ratio and the brachial
artery VTI ratio was observed in both cohorts (Figure 2C, 2D). A similar correlation was
also observed with the reactive hyperemia-induced increase in blood flow relative to
baseline (HV: rs=0.41, P=0.012; CAD: rs=0.65, P<0.001). Although the relationship
between the digital PAT and brachial artery VTI ratio persisted after adjusting for age, sex,
and race (HV: rs=0.48, P=0.004; CAD: rs=0.66, P<0.001), the correlations were
substantially weakened after also adjusting for baseline digital PVA (HV: rs=0.19, P=0.272;
CAD: rs=0.34, P=0.001) or baseline brachial artery VTI (HV: rs=0.25, P=0.145; CAD:
rs=0.11, P=0.295). Moreover, no significant relationship between SSRH and the digital PVA
following reactive hyperemia was observed in either the healthy volunteer (rs=0.05,
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P=0.748) or CAD (rs=0.13, P=0.244) cohort. Similar results were observed in each 30-
second post-cuff deflation interval (data not shown), further demonstrating the lack of a
relationship between digital PAT and brachial artery ultrasound phenotypes following
reactive hyperemia.
After stratifying the CAD cohort by sex, disease severity, a recent revascularization
procedure, and use of clopidogrel, beta blockers or renin-angiotensin system inhibitors,
similar relationships between each basal and reactive hyperemia-evoked digital PAT and
brachial artery ultrasound phenotype were observed within all subsets of the population
(data not shown).
DISCUSSION
Digital PAT is an emerging, automated method to non-invasively assess endothelial
function. The physiology underlying this phenotype, however, has remained unclear. In the
current study, we observed a significant positive correlation between baseline digital PVA
and brachial artery blood flow velocity that was independent of arterial diameter. In contrast,
no relationship was observed between the reactive hyperemia-evoked digital PAT ratio and
brachial artery FMD. Furthermore, no correlation was observed between digital PVA and
brachial artery SSRH, which is the stimulus for brachial artery vasodilation and an index of
microvascular function.18,19,22,23 Although a significant positive relationship was observed
between digital PAT ratio and the reactive hyperemia-induced increase in brachial artery
VTI and blood flow, this relationship was driven by the positive correlation between
baseline brachial artery blood flow velocity and baseline digital PVA. Collectively, these
data demonstrate that digital PAT measures of vascular function more closely reflect
brachial artery blood flow velocity under basal conditions than reactive hyperemia-induced
changes in arterial diameter or flow velocity.
It is well established that brachial artery FMD correlates with coronary artery vasodilator
responses, predicts risk of atherosclerosis development and progression, and predicts risk for
adverse cardiovascular events.1 A series of recent studies have demonstrated that the
reactive hyperemia-evoked digital PAT ratio also is predictive of the presence of
cardiovascular disease risk factors4–7 and impaired endothelial-dependent vasodilator
responses in coronary arteries.8,9 Although prior studies have demonstrated a direct
contribution of nitric oxide to brachial artery FMD11 and the digital PAT ratio,12 conflicting
results regarding correlations between these peripheral endothelial function phenotypes have
been reported.5,6,13–15 A significant positive correlation was reported in a small cohort of
healthy volunteers (n=40),13 as well as two cohorts of patients presenting for evaluation of
chest pain (n=89, n=115).14,15 In contrast, no correlation was observed in a subset of the
Framingham Third Generation cohort (n=1843),5 the Gutenberg Heart Study (n=5000),6 or
the current investigation. These findings, coupled with the clear lack of an inverse
correlation between digital PAT ratio and advancing age in multiple studies,3,4,8 suggest that
digital PAT ratio and brachial artery FMD assess distinct vascular phenotypes.
Several important differences across these studies should be considered. First, although
different post-cuff deflation intervals were used to calculate the digital PAT ratio in each
study (90–150 second;13 60–120 second;14,15 90–120 second5), we observed similar
relationships between digital PAT ratio and brachial artery FMD in all post-cuff deflation
intervals. Second, the degree of cardiovascular disease risk varied considerably across the
populations. In the current study, no relationship was observed in either patients with
established CAD, irrespective of disease severity or treatment, or healthy volunteers without
significant CAD risk factors. These data demonstrate that the presence of clinically
Lee et al. Page 5













significant vascular disease does not impact the relationship between digital PAT ratio and
brachial artery FMD.
In the current investigation, and consistent with two prior reports,5,13 no relationship was
observed between the digital PVA following reactive hyperemia and brachial artery SSRH.
In contrast, our investigation is the first to report presence of a significant positive
relationship between baseline digital PVA and baseline brachial artery blood flow velocity.
Importantly, this relationship was independent of sex and arterial diameter, two known
predictors of digital PVA and blood flow velocity,4,14,23,24 and was similar in patients with
CAD as well as healthy volunteers. Although increases in peripheral arterial blood flow
following reactive hyperemia are dependent on nitric oxide availability and more widely
recognized as an index of microvascular function, studies have also demonstrated that higher
basal brachial artery blood flow is associated with the presence of cardiovascular disease
risk factors and may be reflective of a hyperperfusion state and underlying vascular
dysfunction.18,23–25 Indeed, baseline digital PVA also has been associated with the presence
of cardiovascular disease risk factors in prior studies, and these relationships appear stronger
than those reported with the PAT ratio.4,6 Although we acknowledge that our study was not
powered to identify clinical predictors of each vascular function phenotype, or designed to
assess their predictive value, our findings clearly demonstrate that the digital PVA signal
reflects resting peripheral arterial blood flow and suggest that baseline digital PVA is a
vascular phenotype that should be considered in future studies as a potential predictor of
CAD prevalence and risk of adverse cardiovascular events.
Mechanistic studies have demonstrated that inhibition of nitric oxide and prostaglandin
biosynthesis reduces resting forearm blood flow in humans.26 Although the impact of
cyclooxygenase inhibition on basal digital PVA has not been evaluated to date, inhibition of
nitric oxide biosynthesis had no effect in healthy volunteers.12 In contrast, brachial artery
administration of phenylephrine, an α1-adrenergic receptor agonist, reduced digital PVA by
approximately 50%.12 Similarly, α-adrenergic tone is a key regulator of basal forearm blood
flow,27 and represents a potential common mechanism underlying the observed correlation
between baseline digital PVA and brachial artery blood flow velocity. The cross-sectional
design of our investigation, however, did not enable a cause-and-effect evaluation of either
the direction of the observed correlations or the mechanisms underlying these peripheral
vascular function phenotypes, and is a limitation. Moreover, we were unable to elucidate the
direct impact of pharmacotherapy, including the anti-platelet effects of clopidogrel and anti-
adrenergic effects of beta blockers,28,29 on each phenotype in the CAD population. Future
studies remain necessary to dissect the mechanisms underlying the digital PVA phenotype at
baseline and following reactive hyperemia, and the impact of drug therapy. Despite these
limitations, our results clearly demonstrate that digital PAT measures of vascular function
more closely reflect brachial artery blood flow under basal conditions than reactive
hyperemia-induced changes in arterial diameter or flow velocity. These data offer novel
insight into the physiology underlying digital PVA, and provide a foundation for the design
and interpretation of future studies that evaluate the relative utility of digital and brachial
artery vascular function phenotypes as tools to risk stratify and guide the treatment of
patients at risk for adverse cardiovascular events.
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Figure 1. Correlations between digital pulse volume amplitude and brachial artery diameter and
velocity under basal conditions
Correlations between the log10-transformed digital pulse volume amplitude (PVA) at
baseline and the (A, B) brachial artery diameter at baseline, (C, D) log10-transformed
brachial artery velocity-time integral (VTI) at baseline, and (E, F) log10-transformed
brachial artery shear stress at baseline in the (A, C, E) healthy volunteer and (B, D, F) and
coronary artery disease cohorts are presented. The Spearman rank correlation coefficient (rs)
and P-value for each comparison is provided.
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Figure 2. Correlations between digital PAT and brachial artery ultrasound phenotypes following
reactive hyperemia
Correlations between the log10-transformed digital peripheral arterial tonometry (PAT) ratio
and the (A, B) brachial artery flow-mediated dilation (FMD) and (C, D) log10-transformed
brachial artery velocity-time integral (VTI) ratio in the (A, C) healthy volunteer and (B, D)
coronary artery disease cohorts are presented. The Spearman rank correlation coefficient (rs)
and P-value for each comparison is provided.
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Table 1
Study participant characteristics.
Characteristic Coronary Artery Disease (n=99) Healthy Volunteer (n=40)
Age (years) 59 ± 9 51 ± 8 *
Women 33 (33%) 23 (58%) *
African-American 18 (18%) 7 (18%)
Body mass index (kg/m2) 30 ± 6 26 ± 3 *
 ≥ 30 kg/m2 53 (54%) 0 †
Current smoker 23 (23%) 0 †
Diabetes 24 (24%) 0 †
Hypertension 82 (83%) 0 †
Disease Severity
 1-vessel disease 35 (35%) -
 2-vessel disease 36 (36%) -
 3-vessel disease 28 (28%) -
Revascularization Procedure ‡ 65 (66%) -
Systolic blood pressure (mmHg) 136 ± 17 122 ± 14 *
Diastolic blood pressure (mmHg) 80 ± 10 74 ± 8 *
Total cholesterol (mg/dL) 159 (49) 192 (30) *
Low density lipoprotein cholesterol (mg/dL) 85 (41) 117 (30) *
High density lipoprotein cholesterol (mg/dL) 48 (17) 65 (23) *
Triglycerides (mg/dL) 97 (79) 69 (32) *
Total: high density lipoprotein cholesterol 3.4 (1.6) 3.1 (1.4)
High sensitivity C-reactive protein (mg/L) 1.6 (3.3) 0.7 (1.7) *
Statin use 92 (93%) 0 †
Renin-angiotensin system inhibitor use § 61 (62%) 0 †
Beta-blocker use 82 (83%) 0 †
Aspirin use 96 (97%) 0 †
Clopidogrel use 79 (80%) 0 †
Data presented as mean ± standard deviation, median (interquartile range) or count (proportion).
*
P<0.05 versus coronary artery disease.
†
Exclusion criteria in the healthy volunteer cohort.
‡
In the coronary artery disease cohort, 55/99 underwent a percutaneous coronary intervention and 10/99 underwent a coronary artery bypass
grafting procedure between screening and the study visit.
§
Use of either an angiotensin converting enzyme inhibitor or angiotensin receptor blocker.
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